From Wikipedia, the free encyclopedia
Chemical compound
ADB-HEXINACA
Legal status
N -[(2S )-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-hexyl-1H -indazole-3-carboxamide
PubChem
CID
ChemSpider
Formula C 20 H 30 N 4 O 2
Molar mass 358.486 g·mol−1 3D model (
JSmol )
O=C(N[C@@H](C(C)(C)C)C(N)=O)C1=NN(CCCCCC)C2=C1C=CC=C2
InChI=1S/C20H30N4O2/c1-5-6-7-10-13-24-15-12-9-8-11-14(15)16(23-24)19(26)22-17(18(21)25)20(2,3)4/h8-9,11-12,17H,5-7,10,13H2,1-4H3,(H2,21,25)(H,22,26)/t17-/m1/s1
Key:PZMLDAGKYPJWHJ-QGZVFWFLSA-N
ADB-HEXINACA (also known as ADB-HINACA and ADMB-HEXINACA ) is a
cannabinoid
designer drug that has been found as an ingredient in some
synthetic cannabis products, first appearing in early 2021. It is a longer chain
homologue of previously encountered synthetic cannabinoid compounds such as
ADB-BUTINACA and
ADB-PINACA .
[1]
[2] The pharmacology of ADB-HEXINACA and numerous analogues at CB1 and CB2 receptors has been reported.
[3]
See also
References
^ Kronstrand R, Norman C, Vikingsson S, Biemans A, Valencia Crespo B, Edwards D, et al. (November 2021).
"The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons" . Drug Testing and Analysis . 14 (4): 634–652.
doi :
10.1002/dta.3203 .
PMID
34811926 .
S2CID
244490343 .
^ Gilbert N, Costello A, Ellison JR, Khan U, Knight M, Linnell MJ, et al. (December 2021).
"Synthesis, characterisation, detection and quantification of a novel hexyl-substituted synthetic cannabinoid receptor agonist: (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide (ADB-HINACA)" (PDF) . Forensic Chemistry . 26 : 100354.
doi :
10.1016/j.forc.2021.100354 .
^ Sparkes E, Timmerman A, Markham JW, Boyd R, Gordon R, Walker KA, et al. (April 2024).
"Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA" . ACS Chemical Neuroscience .
doi :
10.1021/acschemneuro.3c00818 .
Phytocannabinoids (
comparison )
Cannabibutols Cannabichromenes Cannabicyclols Cannabidiols Cannabielsoins Cannabigerols Cannabiphorols Cannabinols Cannabitriols Cannabivarins Delta-8-tetrahydrocannabinols Delta-9-tetrahydrocannabinols Delta-10-Tetrahydrocannabinols Miscellaneous cannabinoids Active metabolites
Endocannabinoids
Synthetic cannabinoid receptor agonists / neocannabinoids
Classical cannabinoids (dibenzopyrans) Non-classical cannabinoids Adamantoylindoles Benzimidazoles Benzoylindoles Cyclohexylphenols
Eicosanoids
Hydrocarbons Indazole carboxamides Indazole-3- carboxamides Indole-3-carboxamides Indole-3-carboxylates Naphthoylindazoles
Naphthoylindoles Naphthoylpyrroles Naphthylmethylindenes Naphthylmethylindoles Phenylacetylindoles Pyrazolecarboxamides Pyrrolobenzoxazines Quinolinyl esters Tetramethylcyclo- propanoylindazoles Tetramethylcyclo- propanoylindoles Tetramethylcyclo- propylindoles Others
Allosteric
CBR Tooltip Cannabinoid receptor
ligands
Endocannabinoid enhancers (inactivation inhibitors)
Anticannabinoids (antagonists/inverse agonists/antibodies)